1.Clinicopathological Analysis of Female Gastric Cancer - Comparative study according to the sex fo the patients.
Jin Pok KIM ; Hang Jong YU ; Young Chul KIM ; Soo Jin KIM ; Joo Ho LEE ; Han Kwang YANG
Journal of the Korean Cancer Association 1998;30(5):879-885
PURPOSE: The purpose of this study is to evaluate the differences of the clinicopathological features and survival rates in gastric cancer according to the sex of the patients. MATERIALS AND METHODS: We reviewed 5,784 cases of gastric cancer patients who underwent laparotomy at the Department of Surgery, Seoul National University Hospital fmm Jan. 1986 to Dec. 1995. We have analyzed clinicopathologic features including tumor location, Bonmann type, depth of invasicm, lymph node metastasis, distant metastasis, TNM stage, histologic differentiation and survival rates according to the sex of the patients. RESULTS: The mean age of female patients was 52.4 years, which is lower than that of male, 54.8 years. There were no differences in tumor location, Borrmann type, depth of invasion, lymph node metastasis, distant metastasis, TNM stage of tumor between male and female. But there were some differences in histologic differentiation; well- and moderately differentiated cancers were more common in male and signet-ring cell cancers were more common in female. Female shows slightly better prognosis than male. But the prognosis of young female was poorer than that of young male. CONCLUSION: In gastric cancer patients, differences in histologic differentiation and more aggressive nature of the signet-ring cell cancer in female may affect the survival differences according to the sex.
Female*
;
Humans
;
Laparotomy
;
Lymph Nodes
;
Male
;
Neoplasm Metastasis
;
Prognosis
;
Seoul
;
Stomach Neoplasms*
;
Survival Rate
2.Follow-up examination of atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
Jong Seung KIM ; Kyung Yun KIM ; Yu Jin BAEK ; Weung Wook HANG ; Jeong Hee YANG ; Tae U YU
Journal of the Korean Academy of Family Medicine 2001;22(11):1589-1595
BACKGROUND: The New Bethesda System terminology has opened a series of problems about the atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion categories, particularly on their follow up. METHODS: We observe 12300 Pap smear examination, from jan 1995 to Dec 1999, in the Health promotion Center in a university hospital. Subjects were defined a the Health Promotion Center in a university hospital by electrical record and chart review. RESULTS: We find 48 cases of ASCUS and 33 cases of LSIL. When it is followed up by Pap smear, 34 cases of ASCUS are confirmed normal 19 cases(55.9%), benign cellular change 6 cases(17.6%), ASCUS 5 cases(14.7%), HSIL 4 cases(11.8%) and 27 cases of LSIL are confirmed normal 11 cases(40.7%), benign cellular change 3 cases(11.1%), ASCUS 3 cases(11.1%), LSIL 8 cases(29.6%), HSIL 2 cases(7.4%). 14 cases of ASCUS and 23 cases of LSIL are diagnosed by biopsy. Hostologic results of 14 cases of ASCUS are confirmed cervicitis 10 cases(71.4%), Moderate dysplasia 2 cases(14.3%), carcinoma in sute 2 cases(14.3%) and histologic results of 23 cases of LSIL are confirmed cervicitis 15 cases(65.2%), mild dysplasia 3 cases(13%), moderated dysplasia 3 cases(13%), sever dysplasia 1 cases(4.3%), carcinoma in situ 1 case(4.3%). Pap smear only was used for follow-up at family medicine clinic and 14 cases(29.2%), 4 cases(12.1%) are follow-up loss. CONCLUSION: After it is diagnosed ASCUS or LSIL Lesion of Pap smear in healthy care visitors, Follw-up loss is high in only follow-up Pap smear examination and follow-up results are presented more we severe lesions. To reduce follow-up loss, aggressive diagnosis and managements may be needed more than Pap smear follow-up examination.
Biopsy
;
Carcinoma in Situ
;
Diagnosis
;
Follow-Up Studies*
;
Health Promotion
;
Humans
;
Uterine Cervicitis
3.The Effect of Ginseng on the Nutritional Status and the Immune Functions after Curative Operations on Gastric Carcinoma Patients.
Jin Pok KIM ; Hwan Young YOO ; Hang Jong YU ; Han Kwang YANG
Journal of the Korean Surgical Society 1998;54(6):854-862
Ginseng has been used as a herb medicine and a vital-additive drug for a long time, and recently its compositions and its pharmacologic actions have been studied scientifically. Particularly, since the initial reports suggesting that ginseng has an anticancer effect, there have been many other studies of this anticancer effect and its mechanisms. The anticancer effect of ginseng is explainable by two mechanisms: the direct cancer-cell-killing effect and reinforcement of the immune function of the host. The authors performed long-term administration of ginseng to patients with gastric cancer who had undergone curative surgery, observed the subjective symptoms, immune status, and nutritional status, and thereby analyzed the clinical anticancer effect of ginseng. The authors randomly selected 39 patients from among the patients with curative operations for gastric cancer. We divided the patients into two groups: 20 patients formed the study group and were administered red ginseng powder with a dose of 5400 mg per day in the form of capsules for two years postoperatively, and 19 patients formed the control group on which only follow-up was done. All the patients received postoperative adjuvant immunochemotherapy. The authors compared the preoperative and postoperative changes in appetite, the body weight to height ratio, the triceps skinfold thickness, the serum protein, the albumin and transferrin levels, the percentage of lymphocytes and the T-cell percentage in peripheral blood to examine the effect of ginseng on the subjective symptoms, as well as on the immune and the nutritional status. Although our data does not show that the long-term administration of ginseng to gastric cancer patients with curative resections improved the nutritional status, it does suggest that it improved the patients' subjective symptoms and immune functions and prevented postoperative recurrences.
Appetite
;
Body Weight
;
Capsules
;
Follow-Up Studies
;
Humans
;
Lymphocytes
;
Nutritional Status*
;
Panax*
;
Pharmacologic Actions
;
Recurrence
;
Skinfold Thickness
;
Stomach Neoplasms
;
T-Lymphocytes
;
Transferrin
4.A Case of Gastric Adenocarcinoma Presenting as Meningeal Carcinomatosis.
Hong Gi LEE ; Bora LEE ; Sang Min KIM ; Byoung Jo SUH ; Hang Jong YU
The Korean Journal of Internal Medicine 2007;22(4):304-307
Leptomeningeal carcinomatosis occurs in approximately 5% of patients with cancer. The most common cancers involving the leptomeninges are breast, lung cancer and melanoma. However, gastric adenocarcinoma has been rarely reported with leptomeningeal carcinomatosis. The presenting manifestations are usually headache, visual disturbances and seizures. We report a case of leptomeningeal metastasis that presented as a gastric cancer. A 49-year-old woman was admitted to our hospital with the symptoms of headache and melena for 10 days. The endoscopy showed a thickening of the folds of the stomach compatible with the diagnosis of a Borrman type IV gastric cancer. The biopsy revealed a signet ring cell carcinoma. The MRI of brain showed no abnormal findings; however, the patient complained of an intractable persistent headache, nausea and vomiting on admission day 6. The cytology examination of the cerebrospinal fluid supported the diagnosis of metastatic signet ring cell carcinoma.
Adrenal Cortex Hormones
;
Carcinoma, Signet Ring Cell/*diagnosis/pathology/surgery
;
Female
;
Humans
;
Mannitol
;
Meningeal Neoplasms/*diagnosis/pathology/surgery
;
Middle Aged
;
Stomach Neoplasms/*diagnosis/pathology/surgery
5.Immunochemosurgery for Gastric Carcinoma.
Jin Pok KIM ; Hang Jong YU ; Byoung Jo SUH ; Joo Ho LEE
Journal of the Korean Gastric Cancer Association 2001;1(1):17-23
PURPOSE: The purpose of this study is to analyze the clinicopathologic characteristics of gastric cancer patients and to evaluate the survival and prognostic factors and effect of immunochemosurgery for gastric cancer patients. MATENRIALS AND METHODS: The clinicopathologic characteristics were analyzed for 12,277 consecutive patients who underwent operation for gastric cancer from 1970 to 1999. We also evaluated the survival and prognostic factors for 9,262 consecutive patients from 1981 to 1996. The prognostic significance of treatment modality [surgery alone, surgery +chemotherapy, surgery+immunotherapy+chemotherapy (immunochemosurgery)] were evaluated in stage III gastric cancer. RESULTS: The 5-year survival rate (5-YSR) of overall patients was 55.8%, and that of patients who received curative resection was 64.8%. The 5-YSRs according to TNM stage were 92.9% for Ia, 84.2% for Ib, 69.3% for II, 45.8% for IIIa, 29.6% for IIIb and 9.2% for IV. Regarding adjuvant treatment modality, significant survival difference was observed in stage III patients. The 5-year survival rates were 44.8% for immunochemosurgery group, 36.8% for surgery+chemotherapy group and 27.2% for surgery alone group. Curative resection, depth of invasion and lymph node metastasis were the most significant prognostic factors in gastric cancer. CONCLUSION: Consequently, early detection and curative resection with radical lymph node dissection, followed by immunochemotherapy especially in patients with stage III gastric cancer should be recommended as a standard treatment principle for patients with gastric cancer.
Humans
;
Lymph Node Excision
;
Lymph Nodes
;
Neoplasm Metastasis
;
Stomach Neoplasms
;
Survival Rate
6.Clinicopathologic Features of Multiple Synchronous Gastric Cancer.
Jin Bok KIM ; Min Kyu CHOI ; Joo Ho LEE ; Seung Ik AHN ; Soo Jin KIM ; Hang Jong YU ; Han Kwang YANG
Journal of the Korean Cancer Association 1998;30(4):652-659
PURPOSE: With recent advances of diagnostic methods and precise histopathologic examination, the incidence of synchronous multiple gastric cancer has increased. The purpose of this study was to evaluate the clinicopathologic features of patients with synchronous multiple gastric cancer. MATERIALS AND METHODS: We reviewed the clinicopathologic features of 189 patients with synchronous multiple gastric cancer out of 8,101 patients who underwent gastric resections for gastric cancers during 20 years from January 1977 to December 1996 at the Department of Surgery, Seoul National University Hospital, and compared them with single gastric cancer patients. The clinicopathologic features evaluated were age, sex, diagnostic method and accuracy, location of lesions, tumor size, histologic differentiation, Lauren classification, macroscopic classification, depth of invasion, lymph node metastasis, TNM stage, and type of operation and prognosis. RESULTS: The overall incidence of multiple synchronous gastric cancer was 2.33%. The mean age was 57.2 years old (27~84) and peak incidence was sixth decade. Male was predominant, that the sex ratio was 3.9: 1. Multiple gastric cancer was more frequent in old age, male and early gastric cancer patients. The number of lesions ranged from 2 to 5. In most cases, the lesions were located in lower two-thirds of the stomach. However, in 13 cases, lesions were located in both upper one-third and lower one-third. Only 33.3% of multiple cancer was diagnosed preoperatively, with the diagnostic accuracy of GFS was 30.0% and that of UGIS 26.1%. The most frequently missed lesions at preoperative examination were located in upper third of stomach, posterior wall of middle third and anterior wall of lower third of stomach. The most common macroscopic type was Borrmann type III (54.5%) in advanced lesions and type IIc (47.0%) in early lesions. Regarding the histologic differentiation, 58.7% of the cases were of the same differentiation and the cases composed of well differentiated adenocarcinomas were most common. According to the Laurens classification, 66.7% of lesions were intestinal type. As to the progression of the lesions, all lesions were early cancers in 75 cases, advanced cancers in 39 cases and advanced cancers were coexist with early cancers in 75 cases. Lymph node metastasis was less frequent than in single gastric cancer. Total gastrectomy was performed more frequently in multiple cancer patients than in single gastric cancer patients. The 5-year survival rate of patients with multiple gastric cancer was 70.2%, which was not significantly different from that of patients with single gastric cancer. CONCLUSIONS: Surgeons must keep in mind the possibility of multiple gastric lesions. More careful preoperative and intraoperative examination is mandatory to detect the possible accessory lesions, and postoperative periodic follow-up is necessary to detect any missed lesions, especially in the old age, male and early gastric cancer patients.
Adenocarcinoma
;
Classification
;
Follow-Up Studies
;
Gastrectomy
;
Humans
;
Incidence
;
Lymph Nodes
;
Male
;
Neoplasm Metastasis
;
Postoperative Period
;
Prognosis
;
Seoul
;
Sex Ratio
;
Stomach
;
Stomach Neoplasms*
;
Survival Rate
7.Immunoregulatory Effect of Mesima (R) as an Immunotherapeutic Agent in Stage III Gastric Cancer Patients after Radical Gastrectomy.
Jin Pok KIM ; Keon Young LEE ; Hang Jong YU ; Han Kwang YANG
Journal of the Korean Cancer Association 1997;29(3):383-390
PURPOSE: The effectiveness of adjuvant immunotherapy with Mesima (R) in advanced adenocarcinoma of the stomach was evaluated. MATERIALS AND METHODS: 45 patients with stage III gastric cancer after radical gastrectomy were divided into three groups at random. The first group received Mesima. The second group received OK-432 and the third group received no immunotherapeutic agent at all. All three groups received adjuvant chemotherapy using 5-FU and mitomycin-C protocol. The numbers of total T lymphocytes were checked along with the T4 and T8 subpopulation and B lymphocytes and natural killer (NK) cells preoperatively and 9 days, 3 months and 7 months postoperatively. The delayed-type cutaneous hypersensitivity were also checked preoperatively and 3 months and 7months postoperatively. RESULTS: All three groups showed initial decrease in the total T lymphocyte count and T4 lymphocyte count at 9 days postoperatively, which showed gradual increase over the 7 months postoperative period. The Mesima (R)-treated group and OK-432-treated group showed significantly better recovery rate at 7 months postoperatively than the control group. The number of T8 lymphocytes and NK cells also showed initial decrease and later recovery, but there was no significant difference between groups. The number of B lymphocytes showed gradual decrease over 7 months in the Mesima (R)-treated group and the control group, and initial decrease with later increase in the OK-432-treated group, again with no significant difference. The average numbers of positive antigens on delayed cutaneous hypersensitivity test were decreased initially with gradual increase, but there was no significant difference between groups. CONCLUSION: Mesima (R) can be considered as a candidate for safe and effective immunotherapeutic agent in patients with gastric cancer, but the actual benefit in increasing patient survival should be determined through a long term follow-up study.
Adenocarcinoma
;
B-Lymphocytes
;
CD4 Lymphocyte Count
;
CD8-Positive T-Lymphocytes
;
Chemotherapy, Adjuvant
;
Fluorouracil
;
Follow-Up Studies
;
Gastrectomy*
;
Humans
;
Hypersensitivity
;
Immunotherapy
;
Killer Cells, Natural
;
Lymphocyte Count
;
Mitomycin
;
Picibanil
;
Postoperative Period
;
Stomach
;
Stomach Neoplasms*
;
T-Lymphocytes
8.Resection of Hepatic Metastasis of Gastric Cancer.
Seong Yeon CHO ; Seong Woo HONG ; Hang Jong YU ; Hyucksang LEE
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2006;10(2):13-17
PURPOSE: The benefit of surgical resection for hepatic metastasis from gastric cancer still remains unclear. We planned this study to estimate the surgical outcome of hepatic metastasis from gastric cancer. METHODS: Sixteen patients underwent hepatic resections for metastasis from gastric cancer between December 1991 and May 2005. We analyzed 11 patients who had no gross residual tumor after their operations. The clinical and pathological factors were evaluated with the surgical outcomes. RESULTS: Six patients had synchronous metastasis and 5 had metachronous metastasis. The number of hepatic metastases was one in 9 patients, two in 1 patient and four in 1 patient. There was no bilobar metastasis. The extents of the hepatic resections were 3 lobectomies, 4 segmentectomies and 4 wedge resections. There was no operative mortality. There was one postoperative complication, an intra-abdominal abscess, which was cured with percutaneous drainage. The mean survival was 18 months, the median survival was 13 months and the 1-year survival rate was 52.0%. One female patient is still alive 80 months after resection for metachronous hepatic metastasis. There was no statistically significant prognostic factor except for the patients' gender. (p = 0.0378) CONCLUSION: We consider that hepatic resection is a safe and valuable option for the treatment of metastatic gastric cancer.
Abdominal Abscess
;
Drainage
;
Female
;
Hepatectomy
;
Humans
;
Mastectomy, Segmental
;
Mortality
;
Neoplasm Metastasis*
;
Neoplasm, Residual
;
Postoperative Complications
;
Prognosis
;
Stomach Neoplasms*
;
Survival Rate
9.Expression of CD44 Standard, Variant 6 and Relationship to the Lymph Node Metastasis in Gastric Adenocarcinoma.
Joo Ho LEE ; Hang Jong YU ; Byung Jo SUH ; Mee JU ; Hae Kyung LEE ; Jin Pok KIM
Journal of the Korean Cancer Association 2000;32(4):665-673
PURPOSE: The transmembrane glycoprotein CD44 exists in a variety of isoforms generated by alternative splicing of the pre-mRNA. We studied the role of CD44-standard (CD44s) and CD44-variant6 (CD44v6) in gastric adenocarcinoma. MATERIALS AND METHODS: Immunohistochemical staining was performed in 101 patients with gastric adenocarcinoma who underwent radical gastrectomy at KGCC, Seoul Paik Hospital. The relationship of CD44s, CD44v6 expressions to the clinicopathologic parameters, p53 and Ki-67 were evaluated. RESULTS: CD44s and CD44-v6 expressions were found in 56.4% and 48.5%, respectively. CD44s expression was significantly correlated with lymph node metastasis, lymphatic invasion, and Borr mann type. CD44v6 expression was significantly correlated with sex, lymph node metastasis, lymphatic invasion, and perineural invasion and had a tendency toward p53 expression. In inte stinal type adenocarcinoma, CD44s expression had correlations with lymph node metastasis and CD44v6 had correlations with lymph node metastasis, lymphatic invasion. However, in diffuse type adenocarcinoma, CD44s and CD44v6 expressions had correlations with only Borrmann type. In multivariate analysis, lymph node metastasis was the most significant risk factor for CD44s and CD44v6 expressions in total cases and intestinal type adenocarcinoma. CONCLUSION: These data suggest that expression of CD44 v6 may play an important role in the regulation of lymph node metastasis in intestinal type adenocarcinoma of stomach.
Adenocarcinoma*
;
Alternative Splicing
;
Gastrectomy
;
Glycoproteins
;
Humans
;
Lymph Nodes*
;
Lymphatic Metastasis
;
Multivariate Analysis
;
Neoplasm Metastasis*
;
Protein Isoforms
;
Risk Factors
;
RNA Precursors
;
Seoul
;
Stomach
;
Stomach Neoplasms
10.A Case of Advanced Gastric Cancer with Virchow's Node and Lung Metastasis Successfully Resected after Combined Chemotherapy of Taxotere, CDDP, and 5-FU.
Doo Won KIM ; Byoung Jo SUH ; Hang Jong YU ; Jun Hee KIM ; Hye Kyung LEE ; Jin Pok KIM
Journal of the Korean Gastric Cancer Association 2004;4(4):282-285
We report a case of advanced gastric cancer with Virchow's node and lung metastasis that responded remarkably to preoperative chemotherapy. A 47-year-old female patient was diagnosed as having incurable advanced gastric cancer with Virchow's node and multiple lung metastasis. Preoperative chemotherapy with Taxotere, CDDP and 5FU was carried out. After four courses of the regimen, the Virchow's node and the lung metastasis had disappeared, and a marked reduction of the gastric lesion was observed on the CT scan. Consequently, the patient underwent a total gastrectomy with D2 lymph node dissection. On histopathological examination, cancer cells were found to have infiltrated up to the muscle layer of the gastric wall, and 42 out of 60 resected lymph nodes were found to be metastatic. The patient received another two courses of chemotherapy after the operation
Drug Therapy*
;
Female
;
Fluorouracil*
;
Gastrectomy
;
Humans
;
Lung*
;
Lymph Node Excision
;
Lymph Nodes
;
Middle Aged
;
Neoplasm Metastasis*
;
Stomach Neoplasms*
;
Tomography, X-Ray Computed